ALTERNATIVE CANCER SOLUTION

 Stomach Cancer

In a large-scale study performed on 5,400 patients with stomach cancer, Dr. J.P. Kim was able to attain an increase in the five-year survival rate in more than 50 percent of patients through the administration of systemic oral enzymes with picibanil (OK-432), an immunomodulatory extract derived from Streptococcus pyogenes. The enzyme had both an immunoregulatory effect and inhibited metastasis.

The study impressively demonstrated the highly improved immune status in patients treated with the WOBE-MUGOS preparation. The therapy with picibanil and systemic oral enzymes also improved natural killer cells' ability to destroy cancer cells.
In another prospective, randomized, placebo-controlled clinical study, patients receiving adjuvant therapy with systemic oral enzymes experienced half the rate of death and recurrency..

back to Vitamin C page

 

Staff
Our staff strives to deliver the best service to our patients. We always make the extra effort that makes our members feel valued and respected. Not only do we provide great results but we also deliver a great experience.

Appointments
Our staff strives to deliver the best service to our patients. We always make the extra effort that makes our members feel valued and respected. Not only do we provide great results but we also deliver a great experience.

Biographies
Mark A Rosenberg, MD
Pascal Durand, Nutritional Consultant
Breshan Nelson, Office Manager
Dr Rosenberg In The News